|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/24 | |
| C07K 16/22 | |||
| A61K 39/395 | |||
| C12N 15/13 |
| (11) | Number of the document | 2752428 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14162664.8 |
| Date of filing the European patent application | 2009-06-25 | |
| (97) | Date of publication of the European application | 2014-07-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-13 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 75697 P | 2008-06-25 | US | |
| 75692 P | 2008-06-25 | US | |
| 155041 P | 2009-02-24 | US | |
| 155105 P | 2009-02-24 | US | |
| 8322009 | 2009-06-02 | CH |
| (72) |
Borras, Leonardo, CH
Urech, David, CH
|
| (73) |
NOVARTIS AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | Humanization of rabbit antibodies using a universal antibody framework |
| Humanization of rabbit antibodies using a universal antibody framework |